SHL Telemedicine Ltd. announced that after over twenty years with SHL, Erez Nachtomy, CEO of SHL in the past four years will be stepping down as CEO in mid-June 2024. The Board of Directors of the Company will shortly commence a search for a new CEO, both internally and externally.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5 CHF | +4.82% | -3.85% | -28.06% |
May. 21 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Fresh Catalysts | MT |
May. 21 | SHL Telemedicine Launches At-Home Blood Test for Heart Attack Detection in Israel | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.06% | 87.65M | |
-50.07% | 1.87B | |
+78.57% | 584M | |
+4.33% | 448M | |
-73.81% | 116M |
- Stock Market
- Equities
- SHLTN Stock
- News SHL Telemedicine Ltd.
- SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024